End-of-day quote
Korea S.E.
18:00:00 2024-05-09 EDT
5-day change
1st Jan Change
2,100
KRW
-0.47%
+0.24%
-8.10%
MYUNGMOON Pharm co.,Ltd's Equity Buyback announced on May 25, 2023, has expired with 278,592 shares, representing 0.82% for KRW 674.93 million.
The company expired its plan on November 25, 2023.
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
03-20
CI
Tranche Update on MYUNGMOON Pharm co.,Ltd's Equity Buyback Plan announced on May 25, 2023.
11-27
CI
Tranche Update on MYUNGMOON Pharm co.,Ltd's Equity Buyback Plan announced on May 25, 2023.
11-27
CI
MYUNGMOON Pharm co.,Ltd's Equity Buyback announced on May 25, 2023, has expired with 278,592 shares, representing 0.82% for KRW 674.93 million.
11-24
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
11-13
CI
Tranche Update on MYUNGMOON Pharm co.,Ltd's Equity Buyback Plan announced on May 25, 2023.
23-08-28
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-11
CI
MYUNGMOON Pharm co.,Ltd announces an Equity Buyback for KRW 1,000 million worth of its shares.
23-05-24
CI
MYUNGMOON Pharm co.,Ltd authorizes a Buyback Plan.
23-05-24
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-14
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
22-11-13
CI
MYUNGMOON Pharm co.,Ltd(KOSE:A017180) dropped from S&P Global BMI Index
22-09-19
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
22-08-16
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
22-05-13
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
22-03-15
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
21-11-14
CI
M2N Co.,Ltd cancelled the acquisition of an unknow stake in MYUNGMOON Pharm co.,Ltd.
21-11-11
CI
M2N Co.,Ltd agreed to acquire an unknow stake in MYUNGMOON Pharm co.,Ltd.
21-11-03
CI
Woo Seok-min agreed to acquire 2.4% stake in Myungmoon Investment Development Co. Ltd. from MYUNGMOON Pharm co.,Ltd for KRW 2.1 billion.
21-06-24
CI
Myungmoon Pharm. Co., LTD.(KOSE:A017180) added to S&P Global BMI Index
20-09-21
CI
Myungmoon Pharm. Co., LTD.(KOSE:A017180) dropped from S&P Global BMI Index
19-09-23
CI
Myungmoon Pharm. Co., LTD. announced that it has received KRW 15 billion in funding from a group of investors
19-01-28
CI
Myungmoon Pharm. Co., LTD. announced that it expects to receive KRW 15 billion in funding from a group of investors
19-01-24
CI
Myungmoon Pharm. Co., LTD.(KOSE:A017180) added to S&P Global BMI Index
18-09-24
CI
Jong-min Kim acquired 0.93% stake in Myungmoon Pharm. Co., LTD. from Woo, Seok-Min for approximately KRW 300 million.
14-01-09
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
MyungMoon Pharm. Co., Ltd. is a Korea-based company mainly engaged in the manufacture of pharmaceuticals. Its products include ethical (ETC) drugs and over the counter (OTC) drugs. Its ETC drugs include anesthetic agents, digestive system drugs, rheumatoid arthritis remedies, central nervous system drugs, circulatory drugs, anti-depressant agents, anti-diabetic agents, antibiotics, hormone agents, narcotics and drugs for dermatology systems. Its OTC drugs include antinauseant agents, hepatic agents, immunologic agents, antidiarrheal agents, skin external preparations, antiallergic agents, muscle relaxants, cold drugs and parasiticides. The Company is also involved in the operation golf courses. January 2, 2012, the Company completed the merger with its wholly owned subsidiary.
More about the company
1st Jan change
Capi.
-8.10% 51.42M +30.38% 684B +26.51% 568B -4.36% 361B +19.30% 329B +3.73% 284B +16.70% 240B +8.78% 208B -7.93% 200B +7.68% 166B
Other Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1